High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer (Q34235940)

31 July 2017

title

High expression of MAGE-A10 cancer-testis antigen in triple-negative breast cancer (English)

1 reference

31 July 2017

author name string

Tanja Badovinac Črnjević

1

1 reference

31 July 2017

Giulio Spagnoli

2

1 reference

31 July 2017

Antonio Juretić

3

1 reference

31 July 2017

Jasminka Jakić-Razumović

4

1 reference

31 July 2017

Paula Podolski

5

1 reference

31 July 2017

Nera Šarić

6

1 reference

31 July 2017

publication date

25 November 2011

1 reference

31 July 2017

1 reference

31 July 2017

volume

29

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

1586-1591

1 reference

Cancer/testis antigens, gametogenesis and cancer

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

The melanoma antigen genes--any clues to their functions in normal tissues?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Evaluating HER2 amplification and overexpression in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Cancer/testis (CT) antigens: potential targets for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Expression of MAGE tumour-associated antigens is inversely correlated with tumour differentiation in invasive ductal breast cancers: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Multiple cancer/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Expression of MAGE genes in primary and metastatic cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

CT-X antigen expression in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-0120-9

Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events

21 January 2018

1 reference

12 December 2020

Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma

1 reference

12 December 2020

Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.

1 reference

12 December 2020

Cancer-testis antigen expression in triple-negative breast cancer

1 reference

12 December 2020

Ny-ESO-1 expression and immunogenicity associated with transitional cell carcinoma: correlation with tumor grade

1 reference

12 December 2020

Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance

1 reference

12 December 2020

NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study

1 reference

12 December 2020

Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma

1 reference

12 December 2020

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

12 December 2020

The cancer/testis genes: review, standardization, and commentary.

1 reference

12 December 2020

MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy

1 reference

12 December 2020

NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration

1 reference

12 December 2020

An overview of the MAGE gene family with the identification of all human members of the family

1 reference

12 December 2020

Prognostic impact of cancer/testis antigen expression in advanced stage multiple myeloma patients

1 reference

12 December 2020

Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors

1 reference

12 December 2020

10.1007/S12032-011-0120-9

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1052900038

0 references

1 reference